A-beta clearance – a key to treatment or prevention of Alzheimer’s disease

A-beta clearance – a key to treatment or prevention of Alzheimer’s disease

New study provides insight into ways organ systems outside the brain may affect Alzheimer’s disease – In Alzheimer’s disease the brain accumulates a molecule called A-beta that can be quite toxic to brain cells. Many researchers believe that finding ways to clear A-beta may be a key to treatment or prevention of Alzheimer’s disease.

MRI shows brain atrophy pattern that predicts Alzheimer’s Disease

Using special MRI methods, researchers have identified a pattern of regional brain atrophy in patients with mild cognitive impairment (MCI) that indicates a greater likelihood of progression to Alzheimer’s disease. – Researchers have identified a pattern of regional brain atrophy in patients with mild cognitive impairment (MCI) that indicates a greater likelihood of progression to Alzheimer’s disease. Researchers used special MRI methods.

Mediterranean diet improves cognitive impairment in Alzheimer’s disease

Higher adherence to the Mediterranean diet (MeDi) may protect from Alzheimer disease (AD). Its association with mild cognitive impairment (MCI) has been explored and proved in this study. – Eating a Mediterranean diet appears to be associated with less risk of mild cognitive impairment-a stage between normal aging and dementia-or of transitioning from mild cognitive impairment into Alzheimer’s disease.

Insulin may slow or prevent Alzheimer’s disease

Insulin is a possible new treatment for Alzheimer’s disease. Insulin may slow or prevent Alzheimer’s disease. – Insulin, by shielding memory-forming synapses from harm, may slow or prevent the damage and memory loss caused by toxic proteins in Alzheimer’s disease, reported by researchers at Northwestern University.

Autism spectrum disorder linked to preterm birth

New study explores the relationship between preterm birth and autism spectrum disorder. – Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), in collaboration with other medical centers, have found that children born more than three months premature, are at three times the risk for screening positive on the modified checklist for autism in toddlers (M-CHAT).

Retired athletes with mental decline after concussion

Brain function decline in healthy retired athletes who sustained their last sports concussion in early adulthood – Researchers have found the first evidence that athletes who were concussed during their earlier sporting life show a decline in their mental and physical processes more than 30 years later.

Binge drinking culture in young people

This is the time to remind about effects of binge drinking culture in young people, stressed by UK’s Economic & Social Research Council. – As the party season approaches, a timely reminder of the issues surrounding the binge drinking culture are again highlighted by research into ‘young people and alcohol’ a team lead by Professor Christine Griffin, at the University of Bath.

Yeast to identify drugs for Alzheimer’s disease

Yeast could be used to develop a rapid screening process for identifying compounds which inhibit Alzheimer’s disease. – CSIRO scientists have developed a new system to screen for compounds that can inhibit one of the processes that takes place during the progression of Alzheimer’s disease.

Ginkgo biloba does not reduce dementia, Alzheimer’s disease risk

Ginkgo biloba does not reduce dementia or Alzheimer’s disease risk according to Pitt-led study in JAMA. – The medicinal herb Ginkgo biloba does not reduce the risk of dementia or Alzheimer’s disease development in either the healthy elderly or those with mild cognitive impairment, according to a large multicenter trial led by researchers at the University of Pittsburgh School of Medicine.

Health Newstrack